B P Vareldzis1, J Grosset, I de Kantor
1Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Drug resistance in developing countries may be increasing due to underfunded tuberculosis control programs and the HIV epidemic. Resistance surveillance is key to monitoring program efficiency and guiding public health strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: